---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-003764"
form_type: "8-K"
ticker: "EMMA"
cik: "0000822370"
company_name: "Emmaus Life Sciences, Inc."
filed_at: "2023-01-19T23:59:59+00:00"
generated_at: "2026-06-20T13:40:12.505917+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Emmaus Life Sciences grants CEO Yutaka Niihara warrant to purchase 7.5M shares at $4.50

## Summary
- CEO Niihara receives 5-year warrant for 7.5M shares at $4.50, fully vested on grant date.
- Two consultants each receive 5-year warrants for 250K shares at $0.50.
- Non-employee directors granted options for 100K shares each at $4.50, vesting quarterly over 1 year.
- Executives (COO, CFO, others) granted options totaling 850K shares at $4.50 with multi-stage vesting.

## SEC filing metadata
- accession: 0001213900-23-003764
- form_type: 8-K
- ticker: EMMA
- cik: 0000822370
- company_name: Emmaus Life Sciences, Inc.
- filed_at: 2023-01-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/822370/000121390023003764/0001213900-23-003764-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/822370/000121390023003764/ea171706-8k_emmaus.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-003764
- JSON: https://secwatch.observer/filing/0001213900-23-003764.json
- Plain text: https://secwatch.observer/filing/0001213900-23-003764.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.